If approved, garetosmab would be the first and only available treatment shown to reduce the number and volume of new heterotopic bone lesions in adults with FOP TARRYTOWN, N.Y., Feb. 19, 2026 (GLOBE ...

FOP is an ultra-rare genetic disorder characterized by abnormal bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability If approve ...

Q-Sera CEO Michael Grant added, “Japan has a history of innovation in blood collection tubes with Terumo Corporation a leader ...

The first and only cartridge-based FDA-cleared viscoelastic testing platform for obstetrics, the Quantra System provides comprehensive blood analysis, delivering rapid, real-time coagulation insights ...

The 2026 edition of the event saw HORIBA showcasing a comprehensive portfolio of technologies spanning Haematology, ...

More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...

Kochi: Authorities at Govt Medical College, Ernakulam, have started measures to procure a slew of machines required for ...

ANIMAL-TESTING LATEST — The Trump administration got one step closer to its goal of reducing federally funded primate testing ...

DANVILLE, CA, UNITED STATES, February 12, 2026 /EINPresswire.com/ — Rescue Engineers, a longstanding provider of reduction, ...

A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer ...

HORIBA presented a wide portfolio of diagnostic technologies at the WHX 2026, showcasing systems spanning haematology, ...

Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...